BRAF and melanoma: More recent in vitro studies of kinase inhibitor resistance have identified non-genetic mechanisms of resistance such as epigenetic changes in gene expression, and have suggested that there is a wide diversity of such resistance mechanisms, even within genetically homogenous cell including clonal BRAF-V600E melanoma cells (Sharma et al., 2010; Goyal et al., 2023).